Chimera Investment Corporation (CIM) Key Metrics
CIM valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $703.2M
- Enterprise value
- $13.66B
- P/E (TTM)
- — 10-yr median 8.1
- Forward P/E
- 5.3
- PEG ratio
- 3.33
- Price / sales
- 3.2 10-yr median 5.7
- Price / book
- 0.4 10-yr median 0.9
- EV / EBITDA
- — 10-yr median 19.1
- Dividend yield
- 21.43% $1.80 a year
- Beta
- 1.81
CIM key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCIM valuation Price multiples at each fiscal year-end price.
CIM returns How much profit the business earns on the capital it uses.
CIM per-share figures Results divided by the shares outstanding at year-end.
CIM financial health Debt, liquidity and how easily interest is covered.
CIM efficiency & capital use Working capital cycle and where the cash goes.
CIM valuation history
CIM returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CIM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CIM cash returned to shareholders
CIM price vs earnings per share
CIM key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $1.04B | $1.15B | $1.17B | $3.86B | $11.11B | $2.18B | $11.62B | $3.35B | $3.48B | $3.20B |
| Enterprise value | $13.84B | $11.08B | $11.06B | $3.38B | $23.43B | $15.43B | $34.85B | $25.91B | $20.21B | $15.89B |
| P/E ratio | 4.5 | 6.5 | 9.3 | — | 16.6 | 24.6 | 28.1 | 8.1 | 6.6 | 5.8 |
| Price / sales | 1.3 | 4.5 | 5.7 | — | 10.5 | 9.5 | 23.7 | 7.4 | 5.5 | 5.2 |
| Price / book | 0.4 | 0.5 | 0.5 | 1.4 | 3.0 | 0.6 | 2.9 | 0.9 | 1.0 | 1.0 |
| Price / free cash flow | — | 5.6 | 5.5 | 11.9 | 21.4 | 8.5 | 178.7 | 11.2 | 7.1 | 5.8 |
| Price / operating cash flow | — | 5.6 | 5.5 | 11.9 | 21.4 | 8.5 | 178.7 | 11.2 | 7.1 | 5.8 |
| EV / sales | 16.9 | 43.0 | 54.0 | — | 22.2 | 67.4 | 71.0 | 57.2 | 32.1 | 25.9 |
| EV / EBITDA | 17.4 | 16.5 | 17.4 | — | 31.4 | 80.5 | 84.2 | 23.7 | 19.1 | 17.7 |
| EV / free cash flow | — | 53.9 | 51.8 | 10.4 | 45.1 | 59.8 | 535.9 | 87.1 | 41.5 | 28.7 |
| Earnings yield | 22.1% | 15.3% | 10.8% | −13.3% | 6.0% | 4.1% | 3.6% | 12.3% | 15.1% | 17.3% |
| Free cash flow yield | −23.9% | 17.9% | 18.2% | 8.4% | 4.7% | 11.8% | 0.6% | 8.9% | 14.0% | 17.3% |
| Dividend yield | 20.0% | 19.4% | 21.4% | 9.4% | 3.4% | 18.2% | 3.8% | 12.5% | 11.8% | 14.2% |
| Shareholder yield (dividends + buybacks) | 20.0% | 19.4% | 24.2% | 10.6% | 3.4% | 19.2% | 5.5% | 12.9% | 20.9% | 18.6% |
| Share price at fiscal year-end | $12.43 | $14.00 | $14.97 | $16.50 | $45.24 | $30.75 | $61.68 | $53.46 | $55.44 | $51.06 |
| Per share | ||||||||||
| Revenue per share | $9.78 | $3.14 | $2.62 | $0.00 | $4.31 | $3.22 | $2.60 | $7.23 | $10.02 | $9.81 |
| Earnings per share | $2.75 | $2.14 | $1.61 | −$2.19 | $2.73 | $1.25 | $2.19 | $6.58 | $8.36 | $8.81 |
| Operating cash flow per share | −$2.96 | $2.50 | $2.73 | $1.39 | $2.11 | $3.63 | $0.35 | $4.76 | $7.76 | $8.83 |
| Free cash flow per share | −$2.96 | $2.50 | $2.73 | $1.39 | $2.11 | $3.63 | $0.35 | $4.76 | $7.76 | $8.83 |
| Cash per share | $3.32 | $1.02 | $2.84 | $49.69 | $1.57 | $3.79 | $0.58 | $1.36 | $1.79 | $2.99 |
| Book value per share | $30.65 | $30.75 | $32.75 | $11.40 | $15.22 | $53.23 | $20.98 | $59.18 | $57.92 | $49.86 |
| Tangible book value per share | $30.65 | $30.22 | $32.75 | $11.40 | $15.22 | $53.23 | $20.98 | $59.18 | $57.92 | $49.86 |
| Dividends per share | $2.49 | $2.72 | $3.21 | $1.55 | $1.52 | $5.58 | $2.37 | $6.67 | $6.56 | $7.25 |
| Capex per share | $0.46 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | $155.71 | $121.90 | $129.37 | $47.64 | $51.78 | $190.34 | $123.89 | $361.86 | $268.40 | $205.56 |
| Shares outstanding | 83.9M | 82.2M | 78.1M | 233.9M | 245.5M | 71.0M | 188.4M | 62.6M | 62.8M | 62.7M |
| Change in shares outstanding | +2.2% | +5.1% | −66.6% | −4.7% | +245.8% | −62.3% | +201.1% | −0.3% | +0.2% | −5.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 9.0% | 6.9% | 4.8% | −16.0% | 17.8% | 2.3% | 10.8% | 11.2% | 15.5% | 18.2% |
| Return on invested capital (ROIC) | 5.4% | 5.4% | 8.6% | −2.2% | 4.1% | 0.4% | 1.5% | 4.7% | 5.8% | 5.9% |
| Return on assets (ROA) | 1.6% | 1.4% | 1.0% | −3.6% | 4.1% | 0.4% | 1.5% | 1.7% | 2.8% | 3.4% |
| Return on tangible assets | 1.5% | 1.3% | 1.0% | −3.8% | 4.3% | 0.5% | 1.5% | 1.5% | 2.5% | 3.3% |
| Free cash flow margin | −30.3% | 79.7% | 104.2% | — | 49.1% | 112.7% | 13.3% | 65.7% | 77.4% | 90.0% |
| Income quality (OCF / net income) | −1.08 | 1.17 | 1.69 | — | 0.77 | 2.90 | 0.16 | 0.72 | 0.93 | 1.00 |
| Financial health | ||||||||||
| Total debt | $13.07B | $10.01B | $10.11B | $11.15B | $12.71B | $13.51B | $23.34B | $22.65B | $16.85B | $12.88B |
| Cash & short-term investments | $278.6M | $84.1M | $221.7M | $11.62B | $385.7M | $269.1M | $109.9M | $85.0M | $112.5M | $187.4M |
| Net debt | $12.79B | $9.93B | $9.89B | −$478.1M | $12.33B | $13.24B | $23.23B | $22.56B | $16.73B | $12.69B |
| Debt / equity | 5.08 | 3.96 | 3.95 | 4.18 | 3.40 | 3.58 | 5.90 | 6.11 | 4.63 | 4.12 |
| Debt / assets | 0.83 | 0.76 | 0.78 | 0.83 | 0.83 | 0.77 | 0.86 | 0.82 | 0.79 | 0.77 |
| Net debt / EBITDA | 16.09 | 14.76 | 15.55 | — | 16.54 | 69.13 | 56.15 | 20.68 | 15.82 | 14.10 |
| Current ratio | 0.07 | 2.60 | 3.98 | 246.99 | 14.23 | 2.37 | 9.64 | 0.79 | 1.46 | 1.22 |
| Quick ratio | 0.07 | 2.60 | 3.98 | 247.08 | 14.23 | 2.37 | 9.28 | 0.79 | 1.47 | 1.22 |
| Interest coverage | 1.4 | 1.4 | 1.2 | -0.8 | 2.1 | 0.2 | 0.5 | 1.6 | 2.0 | 2.6 |
| Working capital | −$5.64B | $7.00B | $8.77B | $11.64B | $423.3M | $7.78B | $602.8M | −$3.53B | $4.40B | $1.63B |
| Invested capital | $15.36B | $12.46B | $12.45B | $2.19B | $16.06B | $17.02B | $27.19B | $26.26B | $20.37B | $15.81B |
| Tangible asset value | $2.57B | $2.48B | $2.56B | $2.67B | $3.74B | $3.78B | $3.95B | $3.70B | $3.63B | $3.12B |
| Net current asset value | −$12.84B | $776.4M | $1.34B | $950.4M | −$11.22B | −$281.3M | −$22.49B | −$11.02B | −$3.68B | −$4.50B |
| Graham number | $43.51 | $38.50 | $34.48 | — | $30.57 | $38.72 | $32.19 | $93.59 | $104.37 | $99.41 |
| Graham net-net per share | −$153.32 | −$25.67 | −$20.48 | $3.99 | −$45.76 | −$51.28 | −$120.06 | −$231.84 | −$115.36 | −$108.76 |
| Capital allocation | ||||||||||
| Dividends paid | $208.7M | $223.3M | $250.5M | $361.5M | $372.4M | $396.4M | $447.0M | $417.6M | $411.7M | $454.3M |
| Share buybacks (net) | $0 | $0 | $33.1M | $48.9M | $1.8M | $22.1M | $193.4M | $14.8M | $314.4M | $140.1M |
| Dividend payout ratio | 90.6% | 126.8% | 198.7% | — | 55.6% | 446.1% | 108.1% | 101.4% | 78.5% | 82.3% |
| Dividends + buybacks / free cash flow | — | 108.5% | 133.0% | 126.0% | 72.1% | 162.2% | 984.6% | 145.3% | 149.0% | 107.5% |
| Capex / revenue | 4.7% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Capex / operating cash flow | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Capex / depreciation | 5.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Stock-based compensation / revenue | 6.9% | 3.9% | 4.7% | — | 0.6% | 2.2% | 2.2% | 1.9% | 0.6% | 0.4% |
| R&D / revenue | — | — | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A / revenue | 3.7% | 41.1% | 42.1% | — | 6.5% | 30.7% | 15.4% | 20.8% | 12.4% | 11.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 2,515.4 | 15,986.4 | 10,212.7 | — | 2,275.9 | 10,905.9 | 4,884.3 | 10,581.7 | 6,506.6 | 4,016.9 |
| Days of inventory on hand | — | — | -22.9 | -41.5 | — | 8.2 | -2.9 | -21.9 | -18.6 | -12.1 |
| Days payables outstanding | 2,353.0 | 3,276.8 | 1,205.8 | 402.0 | -58.9 | 59.9 | 280.6 | 440.4 | 356.4 | 534.1 |
| Cash conversion cycle (days) | 162.4 | 12,709.6 | 8,983.9 | — | 2,334.7 | 10,854.2 | 4,600.9 | 10,119.4 | 6,131.5 | 3,470.7 |
| Receivables turnover | 0.15 | 0.02 | 0.04 | 0.00 | 0.16 | 0.03 | 0.07 | 0.03 | 0.06 | 0.09 |
| Payables turnover | 0.16 | 0.11 | 0.30 | 0.91 | −6.20 | 6.10 | 1.30 | 0.83 | 1.02 | 0.68 |
| Inventory turnover | — | — | — | — | — | 44.29 | — | — | — | — |
| Asset turnover | 0.06 | 0.02 | 0.02 | 0.00 | 0.06 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 |
| Average receivables | $5.66B | $11.30B | $5.73B | $65.6M | $6.59B | $6.84B | $6.57B | $13.13B | $11.22B | $6.76B |
| Average payables | $271.4M | $334.0M | $107.8M | $39.7M | $71.9M | $90.8M | $611.2M | $868.6M | $560.9M | $554.6M |
| Average inventory | — | — | −$2.0M | −$4.1M | — | $12.5M | −$6.2M | −$43.2M | −$29.3M | −$12.6M |
| Intangibles / total assets | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from CIM's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CIM valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Chimera Investment traded at 4.5 times earnings, against a 10-year median of 8.1. Chimera Investment earned a return on equity of 9.0% and a return on invested capital of 5.4% in fiscal 2025. It ended the year with $13.1 billion of debt and $278.6 million in cash and short-term investments, net debt of $12.8 billion. It returned $208.7 million to shareholders: $208.7 million in dividends and $0 in share buybacks. The share count rose 34.0% from 62.7M to 83.9M over 9 years.
See the CIM income statement, the CIM chart for price history, or the CIM stock overview for the latest quote and news.
CIM key metrics FAQ
What is Chimera Investment's P/E ratio?
Chimera Investment traded at 4.5 times earnings at the end of fiscal 2025.
What is Chimera Investment's EV/EBITDA?
Chimera Investment's enterprise value was 17.4 times EBITDA at the end of fiscal 2025 (enterprise value $13.8 billion, EBITDA $794.9 million).
What is Chimera Investment's return on equity?
Chimera Investment's return on equity (ROE) was 9.0% in fiscal 2025: net income of $230.5 million on average shareholders' equity of $2.5 billion.
What is Chimera Investment's ROIC?
Chimera Investment's return on invested capital was 5.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Chimera Investment have?
Chimera Investment had total debt of $13.1 billion at the end of fiscal 2025, a debt-to-equity ratio of 5.08 and $12.8 billion of net debt (16.09 times EBITDA).
What is Chimera Investment's dividend yield?
Chimera Investment's forward dividend yield is 21.43%. Chimera Investment paid $208.7 million in dividends in fiscal 2025 ($2.49 per share), a payout ratio of 90.6%.
What is Chimera Investment's free cash flow yield?
Chimera Investment generated -$248.9 million of free cash flow in fiscal 2025, a free cash flow yield of −23.9% on its market value at year-end ($1.0 billion).
What is Chimera Investment's current ratio?
Chimera Investment's current ratio was 0.07 at the end of fiscal 2025: current assets were 0.07 times current liabilities.